ORIGINAL RESEARCH
Published on 02 Dec 2025
Targeting PSMB5-induced PANoptosis in bladder cancer: multi-omics insights and TCM candidate discovery
doi 10.3389/fimmu.2025.1656682
- 203 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- New Challenges in Cancer Immunotherapy: Mechanisms, Translational Approaches, and Pan-Tumor Strategies
New Challenges in Cancer Immunotherapy: Mechanisms, Translational Approaches, and Pan-Tumor Strategies
201
Total downloads
7,159
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 01 Dec 2025
Integrative multi-omics analysis identifies a PTM-related immune signature and IRF9 as a driver in ccRCC
doi 10.3389/fimmu.2025.1707375
- 260 views
ORIGINAL RESEARCH
Accepted on 26 Nov 2025
Influence of Stage-Specific and Location-Related Intratumoral Microbiota on Prognosis and Metabolic Reprogramming in Non-Small Cell Lung Cancer
ORIGINAL RESEARCH
Accepted on 24 Nov 2025
Prognostic Significance of Baseline Systemic Inflammation Markers in PD-L1-Negative Advanced Non-Small Cell Lung Cancer Patients Treated with the BRICS Sequential Regimen
ORIGINAL RESEARCH
Accepted on 21 Nov 2025
Serglycin's Role in Primary Liver Cancer: Insights into Tumor Microenvironment and Macrophage Interaction
ORIGINAL RESEARCH
Accepted on 21 Nov 2025
Integration of single-cell and bulk RNA-seq via machine learning to reveal ferroptosis-and lipid metabolism-driven immune landscape heterogeneity and predict immunotherapy response in colon cancer
- 141 views
ORIGINAL RESEARCH
Accepted on 21 Nov 2025
Multi-omics spatial characteristics of CD8+TRM cells in hepatocellular carcinoma and immunotherapy response prediction
MINI REVIEW
Published on 19 Nov 2025
The “double-edged sword” effect of cytokines in cancer: coexisting opportunities and challenges
doi 10.3389/fimmu.2025.1701405
- 351 views
ORIGINAL RESEARCH
Accepted on 14 Nov 2025
TSC1 Deficiency Drives Immune Evasion in Colorectal Cancer via mTORC1-Mediated Dysregulation of PD-L1 Sialylation
- 103 views
ORIGINAL RESEARCH
Published on 12 Nov 2025
Multi-omics integration identifies ASPH and PTTG1 as potential causal drivers of lung adenocarcinoma progression and immune evasion
doi 10.3389/fimmu.2025.1689275
- 965 views
ORIGINAL RESEARCH
Published on 04 Nov 2025
Adverse pro-tumorigenic effects of IDO1 catalytic inhibitors mediated by the non-enzymatic function of IDO1 in tumor cells
doi 10.3389/fimmu.2025.1680896
- 977 views
REVIEW
Published on 03 Nov 2025
Advances in PD-1 and CTLA-4 dual-target immunotherapy for ovarian cancer
doi 10.3389/fimmu.2025.1686532
- 1,623 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore